These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12188292)

  • 1. Gadobenate dimeglumine (Multihance) in contrast-enhanced magnetic resonance angiography.
    La Ferla R; Daprà M; Hentrich HR; Pirovano G; Kirchin MA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S409-11. PubMed ID: 12188292
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.
    Neira C; Anzidei M; Napoli A; Kirchin MA; Cavallo Marincola B; Zaccagna F; Catalano C; Passariello R; Tedoldi F
    Invest Radiol; 2011 Dec; 46(12):774-82. PubMed ID: 21730871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MultiHance in body MR angiography: personal experiences.
    Ahlström H
    Eur Radiol; 2004 Jun; 14 Suppl 7():O52-4; discussion O61-2. PubMed ID: 15503377
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.
    Gerretsen SC; le Maire TF; Miller S; Thurnher SA; Herborn CU; Michaely HJ; Kramer H; Vanzulli A; Vymazal J; Wasser MN; Ballarati CE; Kirchin MA; Pirovano G; Leiner T
    Radiology; 2010 Jun; 255(3):988-1000. PubMed ID: 20501735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
    Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
    Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries.
    Kroencke TJ; Wasser MN; Pattynama PM; Barentsz JO; Grabbe E; Marchal G; Knopp MV; Schneider G; Bonomo L; Pennell DJ; del Maschio A; Hentrich HR; Daprà M; Kirchin MA; Spinazzi A; Taupitz M; Hamm B
    AJR Am J Roentgenol; 2002 Dec; 179(6):1573-82. PubMed ID: 12438058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
    Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
    J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadobenate dimeglumine (MultiHance) in MR imaging of the CNS: studies to assess the benefits of a high relaxivity contrast agent.
    Essig M
    Acad Radiol; 2005 May; 12 Suppl 1():S23-7. PubMed ID: 16106542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
    Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
    J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses.
    Völk M; Strotzer M; Lenhart M; Seitz J; Manke C; Feuerbach S; Link J
    Radiology; 2001 Aug; 220(2):484-8. PubMed ID: 11477257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast.
    Hylton NM
    AJR Am J Roentgenol; 2003 Sep; 181(3):677-8. PubMed ID: 12933458
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
    Runge VM; Parker JR; Donovan M
    Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of contrast media dose in elliptical ordered MR angiography image quality of the carotid arteries: preliminary results.
    Pavone P; Luccichenti G; Cademartiri F; Ugolotti U
    Acad Radiol; 2002 Aug; 9 Suppl 2():S417-20. PubMed ID: 12188294
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of gadofosveset (Vasovist(®)) with gadobenate dimeglumine (Multihance(®))-enhanced MR angiography for high-grade carotid artery stenosis.
    Amarteifio E; Essig M; Böckler D; Attigah N; Schuster L; Demirel S
    J Neuroradiol; 2015 Jul; 42(4):236-44. PubMed ID: 24996569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
    Lorusso V; Arbughi T; Tirone P; de Haën C
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S181-94. PubMed ID: 10608414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
    Johansson L; Kirchin MA; Ahlström H
    Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies.
    Knopp MV; Schoenberg SO; Rehm C; Floemer F; von Tengg-Kobligk H; Bock M; Hentrich HR
    Invest Radiol; 2002 Dec; 37(12):706-15. PubMed ID: 12447005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe adverse drug reaction to gadobenate dimeglumine.
    Singer BD; Woodrick RS; Pedicano JB
    ScientificWorldJournal; 2009 May; 9():363-5. PubMed ID: 19468658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.